EXAGEN INC. - COMMON STOCK
3.0000
04-October-24 15:59:54
15 minutes delayed
Stocks
+0.0400
+1.35%
Today's range
2.8896 - 3.0300
ISIN
N/A
Source
NASDAQ
-
Exagen Inc. Reports Strong Second Quarter 2023 Results
07 Aug 2023 08:00:01 By Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
26 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
25 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
30 May 2023 09:00:00 By Nasdaq GlobeNewswire
-
Exagen Inc. Reports First Quarter 2023 Results
15 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Announces Campaign for Lupus Awareness Month
01 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
24 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
20 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
06 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in Upcoming March Conferences
27 Feb 2023 09:00:01 By Nasdaq GlobeNewswire
-
30 Jan 2023 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
23 Jan 2023 09:00:00 By Nasdaq GlobeNewswire
-
Exagen Inc. Reports Third Quarter 2022 Results
14 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire
-
Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
31 Oct 2022 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Announces Appointment of John Aballi as CEO
17 Oct 2022 09:00:00 By Nasdaq GlobeNewswire
-
Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
04 Oct 2022 08:25:00 By Nasdaq GlobeNewswire
-
Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting
20 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
01 Sep 2022 16:05:01 By Nasdaq GlobeNewswire
-
Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA
04 Aug 2022 16:06:00 By Nasdaq GlobeNewswire